Treatment of advanced melanoma with laser immunotherapy and ipilimumab.

Naylor, Mark F; Zhou, Feifan; Geister, Brian V; Nordquist, Robert E; Li, Xiaosong; Chen, Wei R

Naylor, Mark F; Zhou, Feifan; Geister, Brian V; Nordquist, Robert E; Li, Xiaosong; Chen, Wei R.

Afiliación

Naylor MF; Baylor Scott & White Healthcare, Waco, Texas, 76712, USA.
Zhou F; Biophotonics Research Laboratory, Center for Interdisciplinary Biomedical Education and Research, University of Central Oklahoma, Edmond, Oklahoma, 73034, USA.
Geister BV; INTEGRIS Cancer Institute, 5915 W. Memorials Rd, Oklahoma City, OK 73142, USA.
Nordquist RE; Immunophotonics Inc., 4320 Forest Park Avenue #303, St. Louis, Missouri, 63108, USA.
Li X; Department of Oncology, the First Affiliated Hospital of Chinese PLA General Hospital, Beijing, 100048, China.
Chen WR; Biophotonics Research Laboratory, Center for Interdisciplinary Biomedical Education and Research, University of Central Oklahoma, Edmond, Oklahoma, 73034, USA.

J Biophotonics ; 10(5): 618-622, 2017 May.

Article en En | MEDLINE | ID: mdl-28417565

Asunto(s)

Inmunoterapia; Ipilimumab/uso terapéutico; Melanoma/terapia; Inmunidad Adaptativa; Anciano; Anticuerpos Monoclonales; Humanos; Rayos Láser; Masculino; Linfocitos T

Palabras clave

Immunotherapy; checkpoint inhibitor; ipilimumab; laser immunotherapy; metastatic melanoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ipilimumab / Inmunoterapia / Melanoma Límite: Aged / Humans / Male Idioma: En Revista: J Biophotonics Asunto de la revista: BIOFISICA Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google